NRAS and acute myeloid leukemia: This dLED discovery confers special relevance to clinically translational therapeutic strategies, as it was proved effective in AML cell lines, further validation in ex vivo analysis and murine models is required but if the result is effective, it could be suggested as a treatment and it could incentivize drug development targeting NRAS and PTPN11.